The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025.

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Shares of Aurora Cannabis Inc. ACB advanced 4.58% to $6.62 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.50 ...

Shares of Aurora Cannabis (NASDAQ:ACB) added ~27% in the premarket on Wednesday after the Canadian marijuana producer reported better-than-expected revenue for Q3 fiscal 2025, thanks mainly to its ...

Shares of Aurora Cannabis Inc. ACB shed 1.40% to $6.33 Wednesday, on what proved to be an all-around mixed trading session ...

Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...

The term of the agreement is for three years with an option to extend and an estimated value of $27 million. EDMONTON — Aurora Cannabis signs a supply agreement with SNDL, a Canadian licensed ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

Driven primarily by its global medical cannabis division, which saw revenue surge 51% YoY to $68.1 million, the firm reported total net revenue of $88.2 million, a 37% year-over-year increase.

A worker looks at cannabis seedlings at the new Aurora Cannabis facility Friday, November 24, 2017 in Montreal. (THE CANADIAN PRESS/Ryan Remiorz) · The Canadian Press Aurora Cannabis (ACB.TO)(ACB) ...